Ssm Formulations Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 08-01-2025
- Paid Up Capital ₹ 5.00 Cr
as on 08-01-2025
- Company Age 12 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 33.50 Cr
as on 08-01-2025
- Revenue 2.63%
(FY 2023)
- Profit 232.25%
(FY 2023)
- Ebitda -7.14%
(FY 2023)
- Net Worth 186.43%
(FY 2023)
- Total Assets -15.15%
(FY 2023)
About Ssm Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 5.00 Cr.
The company currently has active open charges totaling ₹33.50 Cr.
Brajlata Mohata, Vijaysingh Mohta, Uday Mohota, and One other member serve as directors at the Company.
- CIN/LLPIN
U24233MH2012PTC237383
- Company No.
237383
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Oct 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Wardha, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Ssm Formulations Private Limited offer?
Ssm Formulations Private Limited offers a wide range of products and services, including Common Disease Medicines, Cough Syrup, Vitamin Tablets & Capsules.
Who are the key members and board of directors at Ssm Formulations?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Brajlata Mohata  | Managing Director | 23-Sep-2013 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Uday Mohota | Director | 31-Oct-2012 | Current |
| Vijaysingh Mohta | Director | 01-May-2023 | Current |
| Akshay Mohata | Director | 23-Sep-2013 | Current |
Financial Performance of Ssm Formulations.
Ssm Formulations Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.63% increase. The company also saw a substantial improvement in profitability, with a 232.25% increase in profit. The company's net worth Soared by an impressive increase of 186.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ssm Formulations?
In 2023, Ssm Formulations had a promoter holding of 38.34% and a public holding of 61.66%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 19 Apr 2017 | ₹33.50 Cr | Open |
How Many Employees Work at Ssm Formulations?
Ssm Formulations has a workforce of 8 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ssm Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ssm Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
